baber/WOPTO huggingface dataset:
Patent AT-E362624-T1 (AT)
Inventor: DIEBEN EBO
IPC: G06Q10/00
Filed: 1998-11-11
Granted: 2007-06-15
Abstract: The invention relates to a system for the transmittal and receipt of data comprising an electronic data storage device for the electronic storage of data, associated with scattered communication means for procuring data from and transmitting data to the electronic data storage device. The system is used together with separately applied message traffic selected from the group comprising a letter, an e-mail, a facsimile, which selection is provided with a file reference corresponding with data individualized with respect to the recipient of such selection, which data is stored in the electronic data storage device. The electronic data storage device comprises at least one access reference relating to the recipient. Access to the individualized data in the electronic data storage device is released to one of the communication means after the file reference and a reference identical with the access reference has been transmitted by means of said communication means.
Patent AT-E268302-T1 (AT)
Inventor: STRIETZEL ROLAND PROF DR
IPC: B65F3/02
Filed: 1999-03-18
Granted: 2004-06-15
Abstract: Rubbish collection vehicle has a lift and tip device (10) attached to its side for lifting up of a rubbish container (wheelie bin). The lift and tip device can be moved in three directions with respect to the vehicle away from it (X), upwards (Y) and along the length of the vehicle (Z). The holding device (12) for the container has two sensors. The first (optical) sensor emits a light beam such as infrared and is used to detect the edge of the container. The second sensor is a broad beam ultrasonic sensor and is used to determine the distance of the container from its holding device (12).
Patent AT-E214848-T1 (AT)
Inventor: SCHNURR RICHARD
IPC: H02G3/12
Filed: 1999-11-05
Granted: 2002-04-15
Abstract: A clamp (20) is designed with a clamp under part, consisting of steel plate section and essentially including a first tongue at one clamp end, which engages the fastening section (13), and is equipped with at least one cutting edge, which digs in the fastening section. A second tongue is provided at the other clamp end. The second tongue is provided with a projection, so that it engages with spring effect behind the fastener section (13).
Patent AT-E269486-T1 (AT)
Inventor: MAILAENDER UDO
IPC: F02B37/02
Filed: 1999-11-19
Granted: 2004-07-15
Abstract: Using a second and similar pair of turbochargers (A2,B2) for more precise staggering of the charging air supply is allocated to the part of the charging air distributor separable by the flap valve (24). A control device (15) for the finer staging effect is provided for cases where the exhaust rises as compared to when the second turbocharger valve of the first pair is open. The charging performance can be still further increased if a second air distributor (29), subject to valve control in a system of four additional turbochargers, is placed at a second set of cylinder (10) inlet valves (31) separate from the first set of valves (30).
Patent AT-E250282-T1 (AT)
Inventor: GREHANT BERNARD JEAN-PIERRE
IPC: H01L41/04
Filed: 1999-02-10
Granted: 2003-10-15
Abstract: Two phase difference voltages are formed using a capacitor in series with the electrodes such that at a given frequency the current outputs are also in quadrature.
Patent AT-E267206-T1 (AT)
Inventor: ZHANG XINI
IPC: A61K31/70
Filed: 1999-03-03
Granted: 2004-06-15
Abstract: 5-imino-13-deoxy anthracycline derivatives, medical uses of 5-imino-13-deoxy anthracycline derivatives and methods for preparing 5-imino-13-deoxy anthracycline derivatives.
Patent AT-E371022-T1 (AT)
Inventor: DAVIS MARIA
IPC: C12N15/09
Filed: 1999-06-17
Granted: 2007-09-15
Abstract: A purified recombinant thermostable DNA polymerase polymerase which exhibits at least about 80% activity at salt concentations of 50 mM and greater, at least about 70% activity at salt concentrations of 25 mM and greater, and having a processivity of about 30 nucleotides per binding event. An isolated nucleic acid that encodes the thermostable DNA polymerase, as well as a recombinant DNA vector comprising the nucleic acid and a recombinant host cell transformed with the vector, are also disclosed. A method of sequencing DNA using the DNA polymerase as well as a kit for sequencing DNA is also disclosed.
Patent AT-E264838-T1 (AT)
Inventor: GLOCK VOLKER
IPC: C07C323/37
Filed: 1999-06-21
Granted: 2004-05-15
Abstract: The invention relates to a process for preparing 2-nitro-5-(phenylthio)anilines of formula (I)whereinR1 represents hydrogen, C1-C8-alkyl, C3-C8-cycloalkyl, C1-C8-alkoxy, or halogen andR2 represents hydrogen, C1-C8-alkyl, C3-C8-cycloalkyl, C1-C8-alkoxy, halogen, or C6-C10-aryl optionally substituted with C1-C8-alkyl, C1-C8-alkoxy, or halogen, by reacting, in a solvent, a 5-chloro-2-nitroaniline of the formula (II)wherein R1 is as defined for formula (I),with a thiophenol of the formula (III)wherein R2 is as defined for formula (I), andammonia.
Patent AT-E406448-T1 (AT)
Inventor: FARESE ROBERT V JR
IPC: A61K38/00
Filed: 1999-06-23
Granted: 2008-09-15
Abstract: Nucleic acid compositions encoding polypeptide products with diglyceride acyltransferase activity, as well as the polypeptide products encoded thereby and methods for producing the same, are provided. The subject polypeptide and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening applications, as well as in treatment therapies and in the production of triacylglycerols.
Patent AT-E435426-T1 (AT)
Inventor: BARBERA-GUILLEM EMILIO
IPC: C07H21/00
Filed: 1999-11-10
Granted: 2009-07-15
Abstract: Provided are compositions and assay kits comprising functionalized nanocrystals having extending therefrom a plurality of polynucleotide strands of known sequence; wherein primary dots are used to operably link to a molecular probe, and secondary dots comprise a plurality of polynucleotide strands which are complementary to the plurality of polynucleotide strands of the primary dots. Also provided is a method for detecting the presence or absence of target molecule in a sample comprising operably linking primary dots to molecular probe, contacting the complex formed with the sample, contacting the sample with successive additions of secondary dots and primary dots. If target molecule is present in the sample, the primary dots and secondary dots will form dendrimers that can be detected by fluorescence emission.
Patent AT-E316376-T1 (AT)
Inventor: WEIBEL HELLE
IPC: A61K9/14
Filed: 1999-11-29
Granted: 2006-02-15
Abstract: The present invention provides a new stable pharmaceutical composition containing 5-[[4-[3-Methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenyl-methyl]thiadiazolidine-2,4-dione as active ingredient.
Patent DE-1169108-T1 (DE)
Inventor: CHORNET ESTEBAN
IPC: B01D46/38
Filed: 2000-04-07
Abstract: Provided herein is a granular filtration apparatus for the removal of particulate material from hot gas by contacting said hot gas with granular filtration material. The apparatus being of the type having a filtration chamber containing granular filtration material and having a tapered lower portion comprising at least one inlet tubing for feeding therein hot gases to be filtered and at least one outlet tubing for drawing filtered hot gas. The main feature of the present invention consists in a filtration unit mounted in the filtration chamber above each inlet tubing. The filtration unit comprising a first tubular member mounted above the inlet tubing so as to prevent granular material from entering or blocking said inlet tubing and a second tubular member having a bottom and a top end and being mounted essentially in a co-axial and spaced relationship above the first tubular member. During operation, the granular filtration material is siphoned up and fluidized by the hot gases as they travel up the second tubular member, the granular filtration material enters the bottom end of the second tubular member through the space between the first and second tubular member, exits at the top end of the of the second tubular member and falls outside the second tubular member and towards the tapered lower portion of the filtration chamber to be eventually recirculated and fluidized by the hot gases.
Patent DE-04015859-T1 (DE)
Inventor: CHEN JUI-LUNG
IPC: B62B7/06
Filed: 2004-07-06
Abstract: A locking mechanism (1) for a frame unit (9) comprises a base (2), a pivoting member (6) pivotally connected to the base (2), a locking member (3) pivotally connected to lower end of the pivoting member (6), a releasing member (4), whose lower end is adjacent to the locking member (3), mounted to the base (2), and a slide (5) engaged and kept near the base (2) by the locking member (3), whereby the frame unit (9) pivotally connected to the base (2) and the slide (5) is held at a stretched state. When the releasing member (4) is pressed, the locking member (3) is cooperated to disengage the locking member (3) from the slide (5) in order to allow the slide (5) to move away from the base (2), which makes the frame unit (9) be in a foldable state.
Patent DE-19181267-T1 (DE)
Title: Charakterisierung einer fahrzeugkollision
Inventor: STOBBE PAUL
IPC: H04W4/02
Filed: 2019-06-19
Abstract: Verfahren, umfassend:in Reaktion auf das Erlangen von Informationen bezüglich einer möglichen Kollision zwischen einem Fahrzeug und einem Objekt,für eine Zeitspanne, die sich vor und nach einem Zeitpunkt der möglichen Kollision erstreckt, Erlangen von Daten, die das Fahrzeug während der Zeitspanne beschreiben, wobei die Daten, die das Fahrzeug während der Zeitspanne beschreiben und zwar für jeden Zeitpunkt von einer Vielzahl von Zeitpunkten innerhalb der Zeitspanne, Beschleunigungsdaten umfassen, die die Beschleunigung des Fahrzeugs zu dem Zeitpunkt umfassen sowie die Fahrzeuggeschwindigkeit zu dem Zeitpunkt;Klassifizieren der das Fahrzeug beschreibenden Daten unter Verwendung wenigstens eines trainierten Klassifikators in wenigstens eine Klasse aus einer Vielzahl von Klassen, wobei jeder Klasse aus der Vielzahl von Klassen zugeordnet wird, ob eine Kollision aufgetreten ist; undBestimmen, ob es sich bei der möglichen Kollision eher um eine Kollision handelt, die zumindest teilweise auf der wenigstens einen in der Klassifizierung identifizierten Klasse basiert.
Patent DE-100270-T1 (DE)
IPC: B01D25/12
Filed: 1983-07-13
Abstract: 1. A method of extraction of a liquid phase contained in a solid matter reduced to particles similar to a pulp, in accordance with which this matter is divided into at least 20 layers (3) separated by separator elements (2) and the whole is subjected to one pressure, characterized in that the thickness of each layer (3) lies between 0.4 and 1.5 cm ; the minimum value of the pressure is 2.0 MPa ; the time of keeping under pressure lies between 4 minutes and 2 hours ; and the separator elements (2) are woven fabric.
Patent DE-900354-T1 (DE)
Inventor: PATHE CLAUDE
IPC: F42D1/055
Filed: 1997-05-21
Abstract: A control method for detonators (1) fitted with an electronic ignition module (15). Each module (15) is associated with specific parameters including at least one identification parameter and one explosion delay time, and includes a firing capacitor and a rudimentary internal clock. The modules (15) are capable of establishing a dialogue with a firing control unit (17) fitted with a reference time basis. The identification parameters are stored in the modules using a programming unit (18); the specific parameters are stored in the firing control unit (17); for each successive module, its internal clock is calibrated using the firing control unit and the associated delay time is sent to the module; the modules are ordered to load the firing capacitors; and a firing order is sent to the modules using the firing control unit, triggering off eventual resetting of the internal clocks as well as a firing sequence.
Patent ES-2523796-T1 (ES)
Title: Composición farmacéutica de liberación controlada que comprende éster de ácido fumárico
Inventor: NILSSON HENRIK
IPC: A61K9/20
Filed: 2005-10-07
Abstract: Composición farmacéutica de liberación controlada para uso oral que consiste en fumarato de dimetilo como principio activo, en la que la dosificación diaria es de desde 480 hasta 720 mg de principio activo administrado en de una a tres dosis, en la que la composición es para su uso en el tratamiento de una enfermedad autoinmunitaria, en la que la enfermedad autoinmunitaria se selecciona de: i. poliartritis ii. esclerosis múltiple(EM) iii. diabetes mellitus de comienzo juvenil iv. tiroiditis de Hashimoto v. enfermedad de Grave vi. LES (lupus eritematoso sistémico) vii. síndrome de Sjogren viii. anemia perniciosa ix. hepatitis crónica activa (lupoide) x. arthritis reumatoide (AR) xi. neuritis óptica.
Patent ES-2111502-T1 (ES)
Inventor: ESCUDIER JEAN-LOUIS
IPC: C12G3/08
Filed: 1994-08-19
Abstract: The invention relates to a tartaric stabilisation method for wines, comprising the following steps: taking a sample of the wine to be stabilised; determining the specific instability degree of said wine; if the wine is unstable, said wine to be stabilised is treated according to a membrane electrodialysis technique until it becomes stable. The invention also relates to an automatic device for the tartaric stabilisation of wines.
Patent CY-1108999-T1 (CY)
Title: Μεθοδος και συσκευη για εμμεση τηλε-ειδοποιηση ενος ασυρματου τερματικου με λιγοτερο κωδικοποιημενο καναλι ενδειξης τηλε-ειδοποιησης
Inventor: BUTLER BRIAN K
IPC: H04J13/18
Filed: 2007-07-13
Abstract: Μία μέθοδος και μία συσκευή για τηλε-ειδοποίηση ενός ασύρματου τερματικού σε ένα ασύρματο σύστημα τηλεπικοινωνιών μειώνουν την κατανάλωση ισχύος σε κατάσταση αναμονής. Ένα ελάχιστα κωδικοποιημένο κανάλι ταχείας τηλε-ειδοποίησης αποκαθίσταται στο οποίο μεταδίδονται σύντομα μηνύματα ταχείας τηλε-ειδοποίησης (30) κατά τη διάρκεια μίας από ένα σύνολο θυρίδων ταχείας τηλε-ειδοποίησης. Το μήνυμα ταχείας τηλε-ειδοποίησης υποδεικνύει ότι μία αίτηση επικοινωνιών έχει ληφθεί, και ότι τα τερματικά επικοινωνίας λήψης πρέπει να επεξεργάζονται ένα υψηλά κωδικοποιημένο κανάλι πλήρους τηλε-ειδοποίησης στο οποίο μεταδίδονται πιο λεπτομερή μηνύματα πλήρους τηλε-ειδοποίησης (32) κατά τη διάρκεια της επόμενης θυρίδας πλήρους τηλε-ειδοποίησης. Ένα τερματικό παρακολουθεί το κανάλι πλήρους τηλε-ειδοποίησης μόνο αφότου ένα μήνυμα ταχείας τηλε-ειδοποίησης έχει ληφθεί στο κανάλι ταχείας τηλε-ειδοποίησης.
Patent CY-1106861-T1 (CY)
Title: Καψουλα με μεσο στεγανοποιησης
Inventor: YOAKIM ALFRED
IPC: A23L23/00
Filed: 2007-09-12
Abstract: Μία κάψουλα (1) περιέχει συστατικά ροφήματος όπως αλεσμένο καφέ, τσάι ή άλλα συστατικά και είναι διαμορφωμένη για να εισάγεται σε μία συσκευή παραγωγής ροφήματος (2) ώστε ένα υγρό να εισέρχεται υπό πίεση μέσα στην κάψουλα (1) και να αλληλεπιδρά με τα συστατικά (3) μέσα στην κάψουλα (1). Η κάψουλα (1) περιλαμβάνει ένα σώμα βάσης (4) και ένα φυλλοειδές στοιχείο (5) το οποίο κλείνει το σώμα βάσης (4) μέσω στερέωσης του σε μία φλαντζωτή στεφάνη (6) η οποία εκτείνεται από το πλευρικό τοίχωμα (7) του σώματος βάσης (4) της κάψουλας (1). Το σώμα βάσης (4) της κάψουλας (1) περιλαμβάνει ένα εύκαμπτο στοιχείο στεγανοποίησης (8), όπου το στοιχείο στεγανοποίησης (8) είναι σχεδιασμένο ώστε να βρίσκεται σε εμπλοκή στεγανοποίησης με ένα κωδωνοειδές στοιχείο (9) της συσκευής παραγωγής ροφήματος (2).
Patent CY-1107025-T1 (CY)
Inventor: RASMUSSEN JON H
IPC: C07K5/08
Filed: 2007-11-27
Abstract: The invention relates to a process for preparing a tripeptide, including a salt thereof, of the formula (IX) 
Boc-D-2Nal-D-4CIPhe-D-3Pal-OH (IX) 
comprising the following consecutive steps:  (a) Reacting Boc-D-4ClPhe-OH with HONSu to form Boc-D-4ClPhe-OSu (VII);  (b) Reacting Boc-D-4ClPhe-OSu (VII) with H-D-3Pal-OH to form Boc-D-4ClPhe-D-3Pal-OH (VIII);  (c) Reacting Boc-D-4ClPhe-D-3Pal-OH (VIII) with Boc-D-2Nal-OSu prepared by reacting Boc-D-2Nal-OH with HONSu to form Boc-D-2Nal-D-4ClPhe-D-3Pal-OH (IX).
Patent CY-1108452-T1 (CY)
Title: ΠΑΡΑΓΩΓΑ ΙΜΙΔΑΖΟΛΙΟΥ ΚΑΙ ΧΡΗΣΗ ΑΥΤΩΝ ΩΣ ΠΕΡΙΦΕΡΙΚΩΣ ΕΚΛΕΚΤΙΚΩΝ ΑΝΑΣΤΟΛΕΩΝ ΤΗΣ ΝΤΟΠΑΜΙΝΗΣ-β-ΥΔΡΟΞΥΛΑΣΗΣ
Inventor: LEARMONTH DAVID ALEXANDER
IPC: A61P9/00
Filed: 2008-10-24
Abstract: Περιγράφονται ενώσεις του τύπου Ι και μέθοδος παρασκευής αυτών όπου Χ είναι CH2, Ο ή S, και n είναι 1, 2 ή 3, υπό την προϋπόθεση ότι, όταν το Χ είναι CH2, το n δεν είναι 1. Οι ενώσεις έχουν δυνάμει πολύτιμες φαρμακευτικές ιδιότητες για την θεραπεία καρδιοαγγειακών διαταραχών όπως είναι η υπέρταση και η χρόνια καρδιακή ανεπάρκεια.
Patent CY-1110484-T1 (CY)
Inventor: TREMBLAIS MICHEL
IPC: B61L1/20
Filed: 2009-09-02
Abstract: The axle counter has a bridge of magnetic material (24,26,28) mounted longitudinally between consecutive wheels (R) of a bogie of the vehicle. The bridge can be a metal bar carried by the bogie. The bar can be fixed on a perpendicular mounting bar (30) attached to the bogie. An Independent claim is also included for a method of controlling movement of railway vehicles using the counter.
Patent CY-1109873-T1 (CY)
Inventor: KRUMM WOLFGANG
IPC: F23C10/02
Filed: 2010-03-04
Abstract: An apparatus for pyrolysis and gasification of organic substances and mixtures thereof is provided with a pyrolysis reactor ( 1 ), a fluidized-bed firing ( 3 ) for pyrolysis residue, a reaction zone ( 2 ) for the pyrolysis gases ( 13 ) and circulating fluidized-bed material ( 35 ). The pyrolysis reactor ( 1 ) has a sluice for introducing application material ( 10 ) thereinto. An inlet for the fluidized-bed material ( 35 ) is disposed next to the combustion fluidized bed ( 3 ). Transport apparatus ( 14 ) for mixture of solid pyrolysis residue and circulating fluidized bed material ( 35 ) is disposed at or near a bottom of the fluidized bed ( 3 ) and lower end of the pyrolysis reactor ( 1 ). An overflow is situated at or near the top of the fluidized bed ( 3 ) while a heat transfer member is positioned within the reaction zone ( 2 ).
Patent CY-1110292-T1 (CY)
Inventor: SINGH RAJINDER
IPC: A61K31/519
Filed: 2010-03-09
Abstract: The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lups erythematosis and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.
Patent CY-1110232-T1 (CY)
Title: Παραγωγα 2-αρυλ-6-φαινυλ-ιμιδαζο[1,2-α]πυριδιν, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη αγωγη
Inventor: ALMARIO GARCIA ANTONIO
IPC: C07D471/04
Filed: 2010-07-20
Abstract: Η εφεύρεση αφορά σε παράγωγα του γενικού χημικού τύπου (I) στον οποίο : το R1 αντιπροσωπεύει μια ομάδα φαινυλ ή μια ομάδα ναφθυλ, όπου οι δυο ομάδες μπορούν ενδεχομένως να υποκατασταθούν. τα R2 και R3 αντιπροσωπεύουν, ανεξάρτητα το ένα από το άλλο, ένα άτομο υδρογόνου, μια ομάδα (C1-C6)αλκυλ, (C3-C7)κυκλοαλκυλ, (C3-C7)κυκλοαλκυλ(C1-C3)αλκυλεν, ενδεχομένως υποκατεστημένη ∙ μια ομάδα αρυλ ενδεχομένως υποκατεστημένη . το R4 αντιπροσωπεύει ένα άτομο υδρογόνου, μια ομάδα (C1-C6)αλκυλ, (C3-C7)κυκλοαλκυλ, (C3-C7)κυκλοαλκυλ(C1-C3)αλκυλεν, ενδεχομένως υποκατεστημένη ∙ μια ομάδα αρυλ ενδεχομένως υποκατεστημένη από έναν ή περισσότερους υποκατάστατες σε κατάσταση βάσης ή άλατος προσθήκης σε ένα οξύ.
Patent CY-1111736-T1 (CY)
Title: Ισοξαζολινες για τον ελεγχο ασπονδυλων παρασιτων
Inventor: LAHM GEORGE PHILIP
IPC: C07D417/12
Filed: 2011-04-18
Abstract: Αποκαλύπτονται ενώσεις του τύπου (1), συμπεριλαμβανομένων όλων των γεωμετρικών και στερεοϊσομερών, Ν-οξειδίων και αλάτων τους, τύπος (1): όπου τα Α1, Α2, Α3, Α4, Α5 και Α6 επιλέγονται ανεξαρτήτως από την ομάδα που αποτελείται από CR3 και Ν, υπό τον όρον ότι το πολύ 3 από τα Α1, Α2, Α3, Α4, Α5 και Α6 είναι Ν τα Β1, Β2 και Β3 επιλέγονται ανεξαρτήτως από την ομάδα που αποτελείται από CR2 και Ν· το κάθε R3 είναι ανεξαρτήτως Η, αλογόνο, C1-C6 αλκύλιο, C1-C6 αλογονοαλκύλιο, C3-C6 κυκλοαλκύλιο, C3-C6 αλογονοκυκλοαλκύλιο, C1-C6 αλκοξυ, C1-C6 αλογονοαλκοξυ, C1-C6 αλκυλθειο, C1-C6 αλογονοαλκυλθειο, C1-C6 αλκυλσουλφινύλιο, C1-C6 αλογονοαλκυλ-σουλφινύλιο, C1-C6 αλκυλ-σουλφονύλιο, C1-C6 αλογονοαλκυλσουλφονύλιο, C1-C6 αλκυλαμινο, C2-C6 διαλκυλαμινο, -CN ή -ΝO2, και τα R1, R2, R4, R5, W και n είναι όπως ορίζεται στην περιγραφή. Επίσης αποκαλύπτονται συνθέσεις οι οποίες περιέχουν τις ενώσεις του τύπου (1) και μέθοδοι για τον έλεγχο ασπόνδυλου παρασίτου οι οποίες περιλαμβάνουν την επαφή του ασπόνδυλου παρασίτου ή του περιβάλλοντος του με μια βιολογικώς αποτελεσματική ποσότητα μιας ένωσης ή σύνθεσης της εφεύρεσης.
Patent CY-1115575-T1 (CY)
Title: Συνθεση για την αναστολη της καθεψινης κ
Inventor: DAIFOTIS ANASTASIA
IPC: A61P19/10
Filed: 2014-09-23
Abstract: Η παρούσα εφεύρεση αναφέρεται σε μέθοδο αναστολής της επαναρρόφησης οστού σε θηλαστικό που τη χρειάζεται με στοματική φαρμακευτική σύνθεση η οποία περιέχει αναστολέα της καθεψίνης Κ, ή φαρμακευτικώς αποδεκτό άλας του, ή μίγμα τους, σύμφωνα με συνεχές πρόγραμμα το οποίο έχει διάστημα δοσολογίας μια φορά εβδομαδιαίως, δύο φορές εβδομαδιαίως, δύο φορές μηνιαίως ή μια φορά μηνιαίως.
Patent CY-1117330-T1 (CY)
Title: Βενζοδιοξινυλ υποκατεστημενα παραγωγα ινδαζολιου
Inventor: BAYER SCHERING PHARMA AG
IPC: C07D409/14
Filed: 2016-02-03
Abstract: Μια ένωση του τύπου la: (la) Η παρούσα εφεύρεση αφορά νέα ινδαζολυλ παράγωγα, φαρμακευτικές συνθέσεις που περιέχουν τέτοια παράγωγα, διαδικασίες για την παρασκευή τέτοιων νέων παραγώγων και τη χρήση τέτοιων παραγώγων ως φαρμάκων.
Patent CY-1123196-T1 (CY)
Title: Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
Inventor: GRANT GEORGE
IPC: A61K35/74
Filed: 2020-04-30
Abstract: Η εφεύρεση παρέχει συνθέσεις που περιλαμβάνουν βακτηριακά στελέχη για θεραπεία και αποτροπή φλεγμονωδών και αυτοάνοσων ασθενειών.
Patent GR-890300123-T1 (GR)
Title: Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition, processes for their preparation and compositions containing them
Inventor: KURABAYASHI MASAAKI
IPC: C07D309/30
Filed: 1990-01-31
Abstract: Compounds of formula (I): <CHEM> [in which: R represents hydrogen, methyl or hydroxy; X represents an alkyl, alkenyl, cycloalkyl, aryl, aralkyl, or heterocyclic group; A represents a single bond, or an alkylene, alkenylene, alkynylene or alkadienylene group; Y represents hydrogen, or an aryl, cycloalkyl or heterocyclic group] have valuable antihypercholesteremic activities and may be used in the treatment of disorders arising from a blood cholesterol imbalance in humans and other animals. They may be prepared by introducing the group =NO-A-Y in place of an oxygen atom at the 4-position or introducing the group -O-CO-X in place of a hydroxy group at the 1-position in a corresponding compound in which the hydroxy group at the 16 position is protected and deprotecting that group.
Patent SI-1532098-T1 (SI)
Title: Process for preparing nitrooxyderivatives of naproxen
Inventor: DEL SOLDATO PIERO
IPC: C07B61/00
Filed: 2003-08-06
Abstract: The present invention refers to a process for preparing a compound of general formula (A), as reported in the description, wherein R is a radical of a drug and R1-R12 are hydrogen or alkyl groups, m, n, o, q, r and s are each independently an integer from 0 to 6, and p is 0 or 1, and X is O, S, SO, SO2, NR13 or PR13 or an aryl, heteroaryl group, said process comprising reacting a compound of formula (B) R—COOZ (B) wherein R is as defined above and Z is hydrogen or a cation selected from: Li+, Na+, K+, Ca++, Mg++, tetralkylammonium, tetralkylphosphonium, with a compound of formula (C), as reported in the description, wherein R1-R12 and m, n, o, p, q, r, s are as defined above and Y is a suitable leaving group.